SEC Form 4 · accession 0001161697-18-000300
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J McEnany
Officer — President and CEO · Director
Period of report
May 29, 2018
Accepted (ET)
May 31, 2018 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $3.54 | May 29, 2018 | A | 166,666 | A | May 29, 2019 | May 29, 2025 | Common Stock | 166,666 | 1,516,666 | D |
| Options to purchase common stock | $3.54 | May 29, 2018 | A | 166,667 | A | May 29, 2020 | May 29, 2025 | Common Stock | 166,667 | 1,683,333 | D |
| Options to purchase common stock | $3.54 | May 29, 2018 | A | 166,667 | A | May 29, 2021 | May 29, 2025 | Common Stock | 166,667 | 1,850,000 | D |